PDL BioPharma (PDLI) Misses Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
Net income per diluted share (in dollars per share): 0.08
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Net income per diluted share (in dollars per share): 0.08
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
PDL BioPharma (NASDAQ: PDLI) reported Q2 EPS of $0.47, $0.05 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $138.1 million versus the consensus estimate of $137.75 million.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
